Phototherapy and carcinogenesis;Phototherapie und Karzinogenese

Hautarzt

Volumn 64, Issue 5, 2013, Pages 349-353

  Hofbauer, G ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Basal cell carcinoma; Melanoma; Non melanoma skin cancer; Squamous cell carcinoma; UV light

Indexed keywords

ARTICLE; CARCINOGENESIS; FOLLOW UP; GENITAL SKIN CANCER; GENITAL TRACT CANCER; HUMAN; MELANOMA; PHOTOTHERAPY; SKIN CANCER; SQUAMOUS CELL CARCINOMA; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION;

CARCINOGENESIS; EVIDENCE-BASED MEDICINE; HUMANS; NEOPLASMS, RADIATION-INDUCED; PUVA THERAPY; RISK ASSESSMENT; SKIN NEOPLASMS;

EID: 84877921539     PISSN: 00178470     EISSN: 14321173     Source Type: Journal    
DOI: 10.1007/s00105-013-2587-0     Document Type: Article

References (50)

1. Archier E, Devaux S, Castela E et al (2012) Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol 26(Suppl 3):22-31
2. Aubin F, Puzenat E, Arveux P et al (2001) Genital squamous cell carcinoma in men treated by photochemotherapy. A cancer registry-based study from 1978 to 1998. Br J Dermatol 144:1204-1206
3. Besaratinia A, Synold TW, Chen HH et al (2005) DNA lesions induced by UV A1 and B radiation in human cells: comparative analyses in the overall genome and in the p53 tumor suppressor gene. Proc Natl Acad Sci U S A 102:10058-10063
4. Besaratinia A, Yoon JI, Schroeder C et al (2011) Wavelength dependence of ultraviolet radiation-induced DNA damage as determined by laser irradiation suggests that cyclobutane pyrimidine dimers are the principal DNA lesions produced by terrestrial sunlight. FASEB J 25:3079-3091
5. Cowen EW, Nguyen JC, Miller DD et al (2010) Chronic phototoxicity and aggressive squamous cell carcinoma of the skin in children and adults during treatment with voriconazole. J Am Acad Dermatol 62:31-37
6. Diffey BL, Farr PM (2007) The challenge of follow-up in narrowband ultraviolet B phototherapy. Br J Dermatol 157:344-349
7. Dziunycz P, Iotzova-Weiss G, Eloranta JJ et al (2010) Squamous cell carcinoma of the skin shows a distinct microRNA profile modulated by UV radiation. J Invest Dermatol 130:2686-2689
8. Edstrom DW, Porwit A, Ros AM (2001) Effects on human skin of repetitive ultraviolet-A1 (UVA1) irradiation and visible light. Photodermatol Photoimmunol Photomed 17:66-70
9. El Ghissassi F, Baan R, Straif K et al (2009) A review of human carcinogens - part D: radiation. Lancet Oncol 10:751-752
10. Euvrard S, Morelon E, Rostaing L et al (2012) Sirolimus and secondary skin-cancer prevention in kidney transplantation. N Engl J Med 367:329-339
11. Forman AB, Roenigk HH Jr, Caro WA et al (1989) Long-term follow-up of skin cancer in the PUVA-48 cooperative study. Arch Dermatol 125:515-519
12. Hannuksela-Svahn A, Pukkala E, Koulu L et al (1999) Cancer incidence among Finnish psoriasis patients treated with 8-methoxypsoralen bath PUVA. J Am Acad Dermatol 40:694-696
13. Hannuksela A, Pukkala E, Hannuksela M et al (1996) Cancer incidence among Finnish patients with psoriasis treated with trioxsalen bath PUVA. J Am Acad Dermatol 35:685-689
14. Hearn RM, Kerr AC, Rahim KF et al (2008) Incidence of skin cancers in 3867 patients treated with narrow-band ultraviolet B phototherapy. Br J Dermatol 159:931-935
15. Hofbauer GF, Anliker M, Arnold A et al (2009) Swiss clinical practice guidelines for skin cancer in organ transplant recipients. Swiss Med Wkly 139: 407-415
16. Hofbauer GF, Attard NR, Harwood CA et al (2012) Reversal of UVA skin photosensitivity and DNA damage in kidney transplant recipients by replacing azathioprine. Am J Transplant 12:218-225
17. Hofbauer GF, Bouwes Bavinck JN, Euvrard S (2010) Organ transplantation and skin cancer: basic problems and new perspectives. Exp Dermatol 19:473-482
18. Hu B, Castillo E, Harewood L et al (2012) Multifocal epithelial tumors and field cancerization from loss of mesenchymal CSL signaling. Cell 149: 1207-1220
19. Jensen AO, Thomsen HF, Engebjerg MC et al (2008) Use of photosensitising diuretics and risk of skin cancer: a population-based case-control study. Br J Cancer 99:1522-1528
20. Katz KA, Marcil I, Stern RS (2002) Incidence and risk factors associated with a second squamous cell carcinoma or basal cell carcinoma in psoralen + ultraviolet a light-treated psoriasis patients. J Invest Dermatol 118:1038-1043
21. Kreimer-Erlacher H, Seidl H, Back B et al (2001) High mutation frequency at Ha-ras exons 1-4 in squamous cell carcinomas from PUVA-treated psoriasis patients. Photochem Photobiol 74:323-330
22. Kunisada M, Kumimoto H, Ishizaki K et al (2007) Narrow-band UVB induces more carcinogenic skin tumors than broad-band UVB through the formation of cyclobutane pyrimidine dimer. J Invest Dermatol 127:2865-2871
23. Lim JL, Stern RS (2005) High levels of ultraviolet B exposure increase the risk of non-melanoma skin cancer in psoralen and ultraviolet A-treated patients. J Invest Dermatol 124:505-513
24. Lindelof B, Sigurgeirsson B, Tegner E et al (1999) PUVA and cancer risk: the Swedish follow-up s tudy. Br J Dermatol 141:108-112
25. Maier H, Schemper M, Ortel B et al (1996) Skin tumors in photochemotherapy for psoriasis: a single-center follow-up of 496 patients. Dermatology 193:185-191
26. Marcil I, Stern RS (2001) Squamous-cell cancer of the skin in patients given PUVA and ciclosporin: nested cohort crossover study. Lancet 358:1042-1045
27. McKenna KE, Patterson CC, Handley J et al (1996) Cutaneous neoplasia following PUVA therapy for psoriasis. Br J Dermatol 134:639-642
28. Molho-Pessach V, Lotem M (2007) Ultraviolet radiation and cutaneous carcinogenesis. Curr Probl Dermatol 35:14-27
29. Nataraj AJ, Wolf P, Cerroni L et al (1997) p53 mutation in squamous cell carcinomas from psoriasis patients treated with psoralen + UVA (PUVA). J Invest Dermatol 109:238-243
30. O'Donovan P, Perrett CM, Zhang X et al (2005) Azathioprine and UVA light generate mutagenic oxidative DNA damage. Science 309:1871-1874
31. Paul C, Gallini A, Archier E et al (2012) Evidence-based recommendations on topical treatment and phototherapy of psoriasis: systematic review and expert opinion of a panel of dermatologists. J Eur Acad Dermatol Venereol 26(Suppl 3):1-10
32. Pfeifer GP, Besaratinia A (2012) UV wavelength-dependent DNA damage and human non-melanoma and melanoma skin cancer. Photochem Photobiol Sci 11:90-97
33. Proby CM, Peloux Menage H du, McGregor JM et al (1993) p53 immunoreactivity in cutaneous PUVA tumors is similar to that in other non-melanoma skin neoplasms. J Cutan Pathol 20:435-441
34. Raiss M, Templier I, Beani JC (2004) Skin cancer and psoralen plus UVA: a retrospective study of 106 patients exposed to a great number of PUVA treatments. Ann Dermatol Venereol 131:437-443
35. Seidl H, Kreimer-Erlacher H, Back B et al (2001) Ultraviolet exposure as the main initiator of p53 mutations in basal cell carcinomas from psoralen and ultraviolet A-treated patients with psoriasis. J Invest Dermatol 117:365-370
36. Shafaeddin Schreve B, Anliker M, Arnold AW et al (2012) Pre- and posttransplant management of solid organ transplant recipients: risk-adjusted follow-up. Curr Probl Dermatol 43:57-70
37. Shephard SE, Panizzon RG (1999) Carcinogenic risk of bath PUVA in comparison to oral PUVA therapy. Dermatology 199:106-112
38. Singer JP, Boker A, Metchnikoff C et al (2012) High cumulative dose exposure to voriconazole is associated with cutaneous squamous cell carcinoma in lung transplant recipients. J Heart Lung Transplant 31:694-699
39. Stern RS (1990) Genital tumors among men with psoriasis exposed to psoralens and ultraviolet A radiation (PUVA) and ultraviolet B radiation. The Photochemotherapy Follow-up Study. N Engl J Med 322:1093-1097
40. Stern RS (2001) The risk of melanoma in association with long-term exposure to PUVA. J Am Acad Dermatol 44:755-761
41. Stern RS (2012) The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: a 30-year prospective study. J Am Acad Dermatol 66:553-562
42. Stern RS, Laird N (1994) The carcinogenic risk of treatments for severe psoriasis. Photochemotherapy Follow-up Study. Cancer 73:2759-2764
43. Stern RS, Liebman EJ, Vakeva L (1998) Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA Follow-up Study. J Natl Cancer Inst 90:1278-1284
44. Stern RS, Nichols KT, Vakeva LH (1997) Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA Follow-up Study. N Engl J Med 336:1041-1045
45. Stern RS, Thibodeau LA, Kleinerman RA et al (1979) Risk of cutaneous carcinoma in patients treated with oral methoxsalen photochemotherapy for psoriasis. N Engl J Med 300:809-813
46. Tanew A, Honigsmann H, Ortel B et al (1986) Nonmelanoma skin tumors in long-term photochemotherapy treatment of psoriasis. An 8-year follow-up study. J Am Acad Dermatol 15:960-965
47. Tzung TY, Runger TM (1998) Assessment of DNA damage induced by broadband and narrowband UVB in cultured lymphoblasts and keratinocytes using the comet assay. Photochem Photobiol 67:647-650
48. Weischer M, Blum A, Eberhard F et al (2004) No evidence for increased skin cancer risk in psoriasis patients treated with broadband or narrowband UVB phototherapy: a first retrospective study. Acta Derm Venereol 84:370-374
49. Wolff K, Honigsmann H (1991) Genital carcinomas in psoriasis patients treated with photochemotherapy. Lancet 337:439
50. Wu X, Nguyen BC, Dziunycz P et al (2010) Opposing roles for calcineurin and ATF3 in squamous skin cancer. Nature 465:368-372